• Explore /
  • Poster
  • / An open-label, randomized, multicenter, phase III study of S-1 and cisplatin versus docetaxel and cisplatin in patients with untreated advanced non-small-cell lung cancer.

An open-label, randomized, multicenter, phase III study of S-1 and cisplatin versus docetaxel and cisplatin in patients with untreated advanced non-small-cell lung cancer.

Abstract Poster

Authors

null

Jianxing He

The First Affiliated Hospital of Guangzhou Medical College, Guangzhou,Guangdong Province, China

Jianxing He , Yuankai Shi , Jianhua Chang , Mengzhao Wang , Baohui Han , Xiaoqing Liu , Gongyan Chen , Caicun Zhou , Jiwei Liu , Hongming Pan , Cheng Huang , Shucai Zhang , Jifeng Feng , Xiaoyan Lin , Jie Wang , Jianjin Huang , Fang Li , Shukui Qin , Zhehai Wang , Liwei Wang

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2015 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Lung Cancer—Non-Small Cell Metastatic

Track

Lung Cancer

Sub Track

Metastatic Non–Small Cell Lung Cancer

Clinical Trial Registration Number

Japic CTI-111479

Citation

J Clin Oncol 33, 2015 (suppl; abstr 8039)

DOI

10.1200/jco.2015.33.15_suppl.8039

Abstract #

8039

Poster Bd #

361

Abstract Disclosures

Similar Posters

First Author: Helena Alexandra Yu

First Author: Vassiliki Papadimitrakopoulou

First Author: Tony Mok

First Author: Caicun Zhou